Nursing care
Pyridium and Urinary Analgesics: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Phenazopyridine, known by the brand Pyridium, is a urinary tract analgesic that relieves the burning and urgency of a UTI without treating the infection itself. It turns urine a bright orange-red, can stain contact lenses and clothing, and is limited to about two days of use so it does not mask a worsening or unresolved infection.
Mechanism, simply
Phenazopyridine works as a local analgesic on the lining of the urinary tract, producing a topical numbing effect on the bladder and urethral mucosa. It does not have antibacterial activity, so it has no effect on the organism causing the infection and cannot be used as a substitute for an antibiotic.
Because it only addresses pain and urgency, phenazopyridine is always prescribed alongside, not instead of, a course of antibiotics when the underlying cause is a bacterial UTI. Its short window of use, generally around two days, reflects this supporting role: it bridges the patient through the worst of the symptoms while the antibiotic works, rather than being a treatment in its own right.
Indications you will see on the ward
The most common indication is symptomatic relief during an acute UTI, particularly the dysuria, urgency, and frequency that make the first day or two of infection miserable for the patient before the antibiotic takes effect. It is also used after urologic procedures or minor trauma to the urinary tract, where irritation produces similar burning and urgency without necessarily involving infection.
Because it treats a symptom rather than a cause, phenazopyridine will appear in a case alongside an antibiotic order, and the nursing task is to recognize that both drugs are doing different jobs. If a patient's dysuria persists beyond the short course of phenazopyridine, that is a reason to reassess the underlying infection and antibiotic response, not a reason to simply refill the phenazopyridine.
Assessment before administration
Confirm renal function before administration, since phenazopyridine is excreted renally and is contraindicated in significant renal impairment because it can accumulate to toxic levels. Ask about glucose-6-phosphate dehydrogenase deficiency, because phenazopyridine can precipitate hemolytic anemia in patients with G6PD deficiency, and check for any history of hepatic disease as well, since hepatic impairment is also a caution.
Ask whether the patient wears contact lenses and tell them in advance that the drug will stain lenses if urine or hands contaminate them, since this is a practical detail patients are rarely warned about and will otherwise attribute to something else. Confirm the patient understands the prescribed duration, since taking it beyond the short course prescribed increases the risk of accumulation and toxicity without any added benefit to the underlying infection.
Toxicity and the antidote
Phenazopyridine toxicity presents as methemoglobinemia, which causes cyanosis unresponsive to oxygen, along with pallor, and shortness of breath, and is more likely with overdose, prolonged use beyond the recommended course, or in a patient with renal impairment where the drug accumulates. Hemolytic anemia is the other serious toxicity to watch for, particularly in a patient with undiagnosed G6PD deficiency.
The antidote for methemoglobinemia is methylene blue, given to restore hemoglobin's oxygen-carrying capacity. A pulse oximetry reading that will not correct with supplemental oxygen in a patient on phenazopyridine should raise immediate suspicion for methemoglobinemia and prompt urgent reassessment rather than simply increasing the oxygen flow rate.
Interactions that matter
Phenazopyridine's orange-red urine color change can interfere with urinalysis results and with urine glucose or ketone testing methods that rely on color reaction, so results obtained while the patient is taking it should be interpreted with that in mind. Because it is metabolized and excreted renally, other renally cleared or nephrotoxic drugs should be reviewed in a patient with any degree of renal impairment before phenazopyridine is added.
There is no major interaction that prevents phenazopyridine being given alongside a standard antibiotic course for UTI, which is in fact its typical clinical pairing. The more relevant consideration on the ward is not drug-drug interaction but the assessment interactions above: renal function, G6PD status, and hepatic history, each of which changes whether the drug should be given at all.
What the patient must be told
Tell the patient their urine, and possibly sweat, will turn a bright orange or reddish-orange color, and that this is expected and not a sign of bleeding or worsening infection. Warn them explicitly that this color can permanently stain fabric, and that it can stain contact lenses if urine or unwashed hands come into contact with them, so removing lenses before use or washing hands well afterward is worth mentioning.
Make clear that phenazopyridine treats the pain and burning only and does not treat the infection itself, so the antibiotic course must be completed in full even after the urinary symptoms improve. Reinforce that the course is short, typically about two days, and that persistent symptoms after that point should be reported rather than treated with more phenazopyridine, since continuing it does not address an unresolved infection and adds toxicity risk instead of benefit.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our renal and genitourinary practice questions are the closest set to what this page covers.
Common questions
Is phenazopyridine safe to take with an antibiotic for a UTI?
Yes, phenazopyridine is commonly prescribed alongside an antibiotic, since it manages symptoms while the antibiotic treats the infection. The two are not interchangeable, and the antibiotic course should be completed in full regardless of how quickly the pain resolves.
Why is phenazopyridine only prescribed for about two days?
A short course limits the risk of toxicity, particularly methemoglobinemia and hemolytic anemia, that rises with prolonged or higher-dose use. By the time the short course ends, symptom relief should be handled by the resolving infection and the antibiotic, not by continued phenazopyridine.
What does orange urine from phenazopyridine mean for lab testing?
It can discolor urine samples and interfere with color-based urine test strips, including glucose and ketone testing, so results should be interpreted with the medication in mind. It is a benign, expected color change and not a sign of hematuria, though any new true blood in the urine should still be reported.
What is the priority nursing action if a patient on phenazopyridine develops cyanosis that does not improve with oxygen?
This presentation suggests methemoglobinemia and requires immediate escalation, since supplemental oxygen alone will not correct it. Methylene blue is the antidote used to treat confirmed methemoglobinemia.
Should phenazopyridine be avoided in patients with kidney disease?
Yes, it is contraindicated in significant renal impairment because it is renally excreted and can accumulate to toxic levels. Renal function should be checked before it is given, and any degree of impairment should be flagged to the prescriber before administration.